Share
Animal Drug Compounding Market by Product (CNS Agents, Anti-Infective Agents, Hormones and Substitutes, Anti-Inflammatory Agents, Others), by Animal Type (Companion Animals, Livestock Animals), by Formulation (Injectable Animal Drugs, Oral Animal Drugs, Others) and Region - Global Analysis of Market Size, Share & Trends for 2021-2022 and Forecasts to 2032
Animal Drug Compounding is the act of combining, blending, or modifying substances to produce a treatment specific to the needs of a single animal or a small group of animals. These medications are proved to be extremely important in veterinary medicine. Pharmacy technicians or veterinarians frequently create compounded medications for animals. When the source of the active component is a finished FDA-approved drug instead of than a bulk drug item, the compounding of animal drugs is permitted by the Federal Food, Drug, and Cosmetic Act (FD&C Act). An element used to create a medicine that is then employed as the active ingredient in the completed dosage form of the drug is referred to as a "bulk drug material."
Animal Drug Compounding Market to surpass USD 3.5 billion by 2032 from USD 1.6 billion in 2021 at a CAGR of 7.3% in the coming years, i.e., 2022-32. Animal drug compounding is in greater demand due to rising public awareness of the importance of animal health. Moreover, the Animal Drug Compounding Market significantly contributes to bridging the gap between less readily available licensed pharmaceuticals for animal medication and alternative possibilities for veterinary care. Over the forecast period, these factors are anticipated to drive the market.
Animal Drug Compounding Market is categorized on the basis of Product into CNS Agents, Anti-Infective Agents, Hormones and Substitutes, Anti-Inflammatory Agents, and Others. Among all goods and services, the CNS Agents segment held the higher revenue market share in 2021. The most frequent disorders in dogs and cats with CNS inflammation include seizures, impaired limb coordination, behavioral disturbances, and blindness. CNS agents make up the majority of the market since they actively react to the process and regulate nerve activity.
Animal Drug Compounding Market is categorized on the basis of Animal Type into Companion Animals and Livestock Animals. The demand for Animal Drug Compounding Market is being driven by the companion animal category, which held a larger market share in 2021. Sometimes a pet avoids taking the medication since due to its awful taste, which increases a great chance for compounded drug items. Therefore, compounded medications with tailored formulas are delightfully consumed by animals. Companion animals are therefore anticipated to create a significant demand for compounded medications over the projection period.
To assist veterinary compounding, businesses in the Animal Drug Compounding Market are working harder to keep their full line of chemicals and supplies in stock. The market's manufacturers collaborate closely with the providers of the APIs, flavors, bases, and formulations that the veterinary compounding industry needs. To increase their trust in the market, manufacturers are concentrating on quality control and adherence to strict standards. In addition to dogs and cats, businesses are expanding their compounding capabilities for horses, birds, and other unusual aquatic and avian animals.
Veterinarians are increasingly looking outside the commercial availability of FDA-approved drugs due to the growing concern of pet owners on providing companion animals and non-food aquaculture animals with sufficient medical care. Another important aspect that has boosted income generation for market participants is the demand for high-quality compounded formulas for small-animal veterinarians. Compound veterinary medicines are subject to regulatory scrutiny that is rapidly expanding, which supports the market's ongoing demand for innovation. The Animal Drug Compounding Market is significantly driven by these elements.
The safety of medicine formulations made from scratch is not guaranteed by the FDA. They claim that animal-compound medication compositions could, in some cases, seriously impair animal health. This is caused by a number of things, including mistakes in the compounding of drugs, an imbalance in the amount of active substances, physical and chemical instability, drug contamination, and a shortage of bioavailability in the animal to be medicated. Lack of any regulatory standards to identify the exact required strength of compounded medications as described on the prescription label has hampered animal care in various ways.
Animal Drug Compounding Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. The Animal Drug Compounding Market was dominated by North America, followed by Europe and Asia Pacific. The region's Animal Drug Compounding Market is anticipated to expand due to the high rate of pet ownership and rising veterinary care spending.
In 2019, Europe held a substantial portion of the global market. Animal Drug Compounding Market growth in the area is anticipated to be fueled by an increase in the prevalence of veterinary diseases in European nations and a rise in the use of antibiotic pharmaceuticals for the treatment of veterinary diseases.
The COVID-19 outbreak had a quick and uneven impact on the veterinary pharmaceutical sector. Veterinarian procedures were somewhat hampered by the implementation of lockdown in certain areas. For instance, the American Veterinary Medical Association estimated that in April 2020, the epidemic caused the cancellation of almost 60% of global veterinary practices, and that figure fell by 30% in July 2020. As a result, the COVID-19 impact is anticipated to restrain the development of the global Animal Drug Compounded Market.
|
REPORT ATTRIBUTE |
DETAILS |
|
Market Size Value in 2021 |
USD 1.6 billion |
|
Revenue Forecast in 2032 |
USD 3.5 billion |
|
Growth Rate |
CAGR of 7.3% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Quantitative Units |
Revenue in USD billion and CAGR from 2022 to 2032 |
|
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments Covered |
Product, Animal Type, Formulation, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key Companies Profiled |
Wedgewood Pharmacy, Medisca Inc., Smith Caldwell Drug Store, Miller's Pharmacy, Sixth Avenue Medical Pharmacy, Dougherty's Pharmacy, Triangle Compounding Pharmacy Inc., Chiron Compounding Pharmacy, MEDS Canadian, Aurora Compounding, Pace Pharmacy, Smith’s Pharmacy, Amber Compounding Pharmacy, Victoria Compounding Pharmacy, Pratt’s Compounding Pharmacy, and Other Prominent Players. |
The Animal Drug Compounding Market size was estimated at USD 1.6 billion in 2021 and is expected to reach USD 3.5 billion in 2032.
Animal Drug Compounding is the act of combining, blending, or modifying substances to produce a treatment specific to the needs of a single animal or a small group of animals. These medications are proved to be extremely important in veterinary medicine.
The CNS Agents and Companion Animals segments accounted for the larger share of the Animal Drug Compounding Market.
Key players in the Animal Drug Compounding Market are Wedgewood Pharmacy, Medisca Inc., Smith Caldwell Drug Store, Miller's Pharmacy, Sixth Avenue Medical Pharmacy, Dougherty's Pharmacy, Triangle Compounding Pharmacy Inc., Chiron Compounding Pharmacy, MEDS Canadian, Aurora Compounding, Pace Pharmacy, Smith’s Pharmacy, Amber Compounding Pharmacy, Victoria Compounding Pharmacy, Pratt’s Compounding Pharmacy, and Other Prominent Players.
The main drivers of the Animal Drug Compounding Market are the increasing awareness for the benefits of veterinary compounding for medication delivery in animals and the rising number of product approvals or launches.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
